OBJECTIVE: To characterize common variable immunodeficiency disorder (CVID) in childhood. STUDY DESIGN: We retrospectively investigated clinical findings in 32 children with primary CVID by questionnaire and file review. RESULTS: Clinical presentation included recurrent or chronic respiratory tract infections (88%), sinusitis (78%), otitis media (78%), and intestinal tract infections (34%), mainly with encapsulated bacteria. Meningitis was found in 25%, sepsis in 16%, and pyelonephritis in 16% of patients. Poliomyelitis after vaccination occurred in 2 patients and opportunistic infections occasionally. Allergic disorders were present in 38%, and autoimmune disease in 31% of patients. Eighty percent of the patients underwent surgical procedures because of recurrent infections. Growth retardation was seen in 28% of patients, and 16% showed retarded mental development. Bronchiectasis developed in 34%, and lymphoid proliferative disease in 13%. Incidence of allergic and autoimmune diseases was increased in first-degree relatives with normal immunologic findings. Mean time between symptoms and induction of immunoglobulin substitution therapy was 5.8 years (0.2-14.3). CONCLUSIONS: CVID in children presents with comparable symptoms and disorders as in adults. We found a significant influence on growth and development. The marked delay of diagnosis may be due to overlap with common pediatric disorders, while also reflecting insufficient awareness of these disorders.
OBJECTIVE: To characterize common variable immunodeficiency disorder (CVID) in childhood. STUDY DESIGN: We retrospectively investigated clinical findings in 32 children with primary CVID by questionnaire and file review. RESULTS: Clinical presentation included recurrent or chronic respiratory tract infections (88%), sinusitis (78%), otitis media (78%), and intestinal tract infections (34%), mainly with encapsulated bacteria. Meningitis was found in 25%, sepsis in 16%, and pyelonephritis in 16% of patients. Poliomyelitis after vaccination occurred in 2 patients and opportunistic infections occasionally. Allergic disorders were present in 38%, and autoimmune disease in 31% of patients. Eighty percent of the patients underwent surgical procedures because of recurrent infections. Growth retardation was seen in 28% of patients, and 16% showed retarded mental development. Bronchiectasis developed in 34%, and lymphoid proliferative disease in 13%. Incidence of allergic and autoimmune diseases was increased in first-degree relatives with normal immunologic findings. Mean time between symptoms and induction of immunoglobulin substitution therapy was 5.8 years (0.2-14.3). CONCLUSIONS:CVID in children presents with comparable symptoms and disorders as in adults. We found a significant influence on growth and development. The marked delay of diagnosis may be due to overlap with common pediatric disorders, while also reflecting insufficient awareness of these disorders.
Authors: Jeroen D Langereis; Thijs M A van Dongen; Kim Stol; Roderick P Venekamp; Anne G M Schilder; Peter W M Hermans Journal: Med Microbiol Immunol Date: 2013-06-18 Impact factor: 3.402
Authors: Monica Piquer Gibert; Laia Alsina; María Teresa Giner Muñoz; Ofelia Cruz Martínez; Karen Ruiz Echevarria; Olga Dominguez; Ana María Plaza Martín; Juan I Arostegui; Guillem de Valles; Manel Juan Otero; Maria Anunciacion Martin-Mateos Journal: Eur J Pediatr Date: 2015-03-10 Impact factor: 3.183
Authors: Sang-Hwa Urm; Hyun Don Yun; Yilma A Fenta; Kwang Ha Yoo; Roshini S Abraham; John Hagan; Young J Juhn Journal: Mayo Clin Proc Date: 2013-08 Impact factor: 7.616